All In Biotech

Drug Trial Radar · NCT01995890

Effect of Nepafenac Eye Drops on Intraocular Pressure in Normal Eyes

Effect of Nepafenac Eye Drops on Intraocular Pressure - a Randomized Prospective Study

Last checked: Nov 20, 2026Latest source record: Nov 27, 2013 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 327 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

327

Actual

Start

Dec 2012

Primary completion

Feb 2013

Study completion Apr 2013

Sponsor

Lead sponsor
Dr T V Patel Eye InstituteAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Nov 27, 2013

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Double (investigator, outcomes assessor)
Who can join
All sexes
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The Nevanac product information insert says that it can cause increase in eye pressure in 5-10% of patients. There is very little published literature on the effect of topical Nepafenac eye drops on eye pressure in normal people. The purpose of our study is to report this effect with a working hypothesis that there is no increase in eye pressure following use of Nepafenac eye drops.

Conditions

  • Intraocular Pressure

Interventions

  • nepafenacDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Intraocular pressureTime frame: 4 weeks
  2. Intraocular pressureTime frame: 8 weeks

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Dr TV Patel Eye Insititute

    Vadodara, Gujarat, India

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.